FDA Inspection
Gland Pharma LimitedGland Pharma Limited – FDA Inspection, Apr 20, 2018
Record Details
This FDA Inspection record concerns Gland Pharma Limited, with an inspection on April 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · bcfef7a6-3c1d-45b7-aa02-c938c6c50db1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1052383
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Gland Pharma Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 25, 2025 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| May 24, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 27, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 29, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gland Pharma Limited
- FDA Inspection 1261860 - 2025-02-25
- FDA Inspection 1245692 - 2024-05-24
- FDA Inspection 1199204 - 2023-01-27
- FDA Inspection 951916 - 2015-10-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.